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CD44 is a broadly distributed polymorphic glycoprotein that serves as the principal cell-surface receptor for 
hyaluronate. Although CD44-mediated cell interaction with hyaluronate has been implicated in a variety of 
physiologic events, including cell-cell and cell-substrate adhesion, cell migration, proliferation, and 
activation, as well as hyaluronate uptake and degradation, the biologic role of CD44 in vivo in various tissues 
remains to be determined. In the present work we have developed transgenic mice that express an antisense 
CD44 cDNA driven by the keratin-5 promoter. These mice lack detectable CD44 expression in skin 
keratinocytes and corneal epithelium and display abnormal hyaluronate accumulation in the superficial 
dermis and corneal stroma, distinct morphologic alterations of basal keratinocytes and cornea, and defective 
keratinocyte proliferation in response to mitogen and growth factors. These alterations are reflected by a 
decrease in skin elasticity, impaired local inflammatory response and tissue repair, delayed hair regrowth, and 
failure of the epidermis to undergo hyperplasia in response to carcinogen. Our observations indicate that two 
major functions of CD44 in skin are the regulation of keratinocyte proliferation in response to extracellular 
stimuli and the maintenance of local hyaluronate homeostasis. 
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CD44 is a polymorphic integral membrane glycoprotein 
whose diversity is determined by variable exon usage, 
glycosaminoglycan substitution, and cell type-specific 
N- and O-linked glycosylation (Stamenkovic et al. 1991; 
Screaton et al. 1992; Lesley et al. 1993; Bennett et al. 
1995). Thus, CD44 proteins range from 90 kD for the 
standard isoform, which contains no variant exon prod- 
ucts--usually referred to as CD44H--to >250 kD for iso- 
forms containing all of the variant exon products and 
high molecular weight glycosaminoglycans. CD44H is 
the isoform expressed most broadly, and is found on both 
mesenchymal nd epithelial cells. Variant exon-contain- 
ing CD44 isoforms have a more restricted expression 
pattern and are found chiefly in cells of epithelial origin 
(Stamenkovic et al. 1991). 
3Corresponding author. 
E-MAIL stamenkovic@helix.mgh.harvard.edu; FAX (617) 726-5684. 
Although CD44 has been proposed to bind multiple li- 
gands, including collagens, fibronectin (Jalkanen and Jal- 
kanen 1992), chondroitin sulfate (Naujokas et al. 1993), 
osteopontin (Weber et al. 1996), and at least two heparin- 
binding growth factors (Bennett et al. 1995), it is cur- 
rently thought o be the principal cell-surface receptor 
for hyaluronate [(HA) Aruffo et al. 1990; Miyake et al. 
1990b]. HA is a ubiquitously distributed, negatively 
charged high molecular weight polysaccharide composed 
of glucuronic acid and N-acetylglucosamine disaccharide 
repeats (Fraser and Laurent 1989; Laurent and Fraser 
1992). The HA polymer can adopt a coil structure in 
solution that becomes a highly hydrated sphere capable 
of accommodating several orders of magnitude more wa- 
ter than polymer (Laurent and Fraser 1992). HA may 
therefore help create  hydrated, low-resistance matrix 
that facilitates cell trafficking. However, together with 
several proteoglycans and HA-binding proteins, HA also 
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plays an important role in organizing the extracellular 
matrix (ECM) structure. HA production is enhanced in 
situations associated with cell proliferation, including 
limb development, issue remodeling, inflammation, 
and tumor invasion (Toole 1982), and recent evidence 
indicates that HA may have a significant part in modu- 
lating cell proliferation, migration and activation in vitro 
and in vivo (Toole 1982, 1990). 
CD44 has been implicated in cell-cell adhesion and 
cell attachment to ECM (Lesley et al. 1993), cell migra- 
tion (Thomas et al. 1992), tissue remodeling, lymphocyte 
recirculation, and homing (Jalkanen et al. 1986), hema- 
topoiesis (Miyake et al. 1990a), lymphocyte activation 
(Shimizu et al. 1989), and tumor growth and metastasis 
(Gunthert et al. 1991; Sy et al. 1991; Bartolazzi et al. 
1994). Most of these functions can be attributed, at least 
in part, to CD44-HA interaction. In addition, several 
lines of evidence indicate that CD44 can mediate HA 
uptake and degradation (Culty et al. 1992). However, de- 
spite abundant evidence of its involvement in multiple 
physiologic and pathologic processes, the main biologic 
roles of CD44 in specific tissues where it is permanently 
expressed remain to be elucidated. 
Basal keratinocytes of the skin display a high level of 
CD44 expression. This raises questions as to the role of 
CD44 in skin tissular organization and in a variety of 
skin processes associated with HA production and po- 
tentially involving CD44-HA interaction, such as 
wound healing, tissue remodeling, and inflammation. To 
address the physiologic role of CD44 in this location, we 
developed transgenic mice with a keratinocyte-specific 
CD44 expression defect. Our results show that CD44 
borne by keratinocytes plays a major role in the regula- 
tion of keratinocyte proliferation and local HA metabo- 
lism. 
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Figure 1. The K5-CD44AS transgene construct, identification 
of transgenic mice, and analysis of transgene expression. (A) 
Schematic representation of the K5-CD44AS transgene con- 
struct. In an antisense orientation 1.1 kb of the entire murine 
CD44H (mCD44H) cDNA (solid box) was cloned downstream 
of the 5.2-kb bovine keratin 5 promoter (K5p) (stippled box) 
between the rabbit ~-globin i tron (~gint) (connecting line) and 
the polyadenylation site (~gpA) (open box). Short arrows indi- 
cate primers used to determine antisense RNA expression. (S) 
SalI; (B) BamHI; (N) NotI. (B) Southern blot analysis of BamH1- 
digested mouse tail DNAs (10 pg each) from founder (Fo) mice. 
The blot was hybridized with radiolabeled entire mCD44H 
cDNA. Expected bands were 0.9 and 1.3 kb. (C) Antisense CD44 
RNA expression i F o transgenic mice. Reverse-transcribed to- 
tal RNA from dorsal skin of mice was subjected to PCR using 
antisense CD44 and polyadenylation sequence-specific oligo- 
nucleotides, followed by Southern blot analysis with radiola- 
beled mCD44H cDNA. The expected message was 0.6 kb. 
Resu l ts  
Development of K5-CD44-antisense transgenic mice 
The DNA construct used to generate the transgenic mice 
is shown in Figure 1A. The 5.2-kb fragment of the 5' 
regulatory region of the bovine keratin-5 (K5) gene used 
to promote xpression of the antisense CD44 cDNA has 
been shown to target he expression of reporter genes to 
the basal cell compartment of stratified squamous epi- 
thelia and the outer root sheath (ORS) of hair follicles 
(Ramirez et al. 1994). Southern blot analysis of tail-de- 
rived DNA identified five founder mice each harboring 
between a few to up to 40 copies of the transgene (Fig. 
1B). Expression of the transgene, as detected by RT-PCR 
using antisense CD44 sequence-specific oligonucleotide 
primers, was observed in the five founder mice (Fig. 1C). 
Immunofluorescence microscopy of dorsal skin sections 
from two of these mice (lines 3 and 10), using an anti- 
CD44 antibody that recognizes epitopes common to all 
isoforms, revealed complete loss of CD44 expression in 
all layers of the epidermis and the ORS of hair follicles. 
Suppression of CD44 expression was confirmed by im- 
munofluorescence and Western blot analysis of cultured 
transgenic mouse-derived keratinocytes and correspond- 
ing lysates (data not shown). In contrast, increased CD44 
expression was observed in the superficial dermis (Fig. 2), 
consistent with an increase in the number of local fibro- 
blasts (see below). Almost all of the observations re- 
ported below are derived from the progeny of founder no. 
3; double transgenic mice resulting from the crossing of 
lines 3 and 10 had the same phenotype as mice having a 
single transgenic onstruct. 
Of 36 F1 progeny obtained by crossing the two trans- 
genic founders with C57BL/6 mice, 24 revealed the pres- 
ence of the transgene as detected by Southern blot analy- 
sis. Newborn transgenic mice displayed no gross skin 
anomaly. Development of the first coat and progression 
of the second and third hair cycles proceeded with no 
notable difference with respect o control littermates. 
However, adult mice from each transgenic line displayed 
abnormally abundant hair loss following fights with 
other male littermates (data not shown). Hair regrowth 
in the transgenic animals required months compared to 
2 weeks in nontransgenic littermates. 
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Figure 2. Immunohistological analysis of CD44 expression in 
transgenic skin. Frozen serial skin sections of control littermate 
(A) and transgenic (B) mice were stained with anti-mouse CD44 
followed by fluorescein-conjugated goat anti-rat immunoglobu- 
lin antibody. Epidermis of control ittermate shows intense im- 
munoreactivity (A}, whereas CD44 staining is lost in transgenic 
epidermis (B). Note the increased CD44 staining in the super- 
ficial dermis of the transgenic mouse. Original magnification, 
40x. 
Loss of keratinocyte CD44 expression is associated 
with structural epidermal and dermal alterations 
Histologic examination of skin sections from >20 adult 
transgenic mice showed characteristic changes in the 
basal ayer of the epidermis, where cells had adopted an 
elongated rather than their characteristic round shape, 
and in the superficial dermis, mainly at the dermoepi- 
dermal junction, where an accumulation of loose con- 
nective tissue replacing the denser collagen layer, with 
the occasional appearance of small empty-looking vacu- 
oles, was observed (Figure 3A, B,G,H). The dermal 
changes were most conspicuous in sections tained with 
van Gieson-elastin (Fig. 3C,D). Ultrastructural nalysis 
showed that the desmosomes and hemidesmosomes, a  
well as keratinocyte differentiation, were normal. Al- 
though the epidermal basement membrane thickness 
and appearance w re unaltered, electron microscopy un- 
derscored the severity of collagen fiber disorganization i  
the dermis and revealed accumulation of large vacuoles 
or the presence of lacunar egions beneath the basement 
membrane (Fig. 3I,J,K). In addition, superficial dermis fi- 
broblasts displayed an abnormal phenotype, character- 
ized by enlarged and convoluted nuclei, a markedly de- 
veloped endoplasmic reticulum, frequently displaying 
striking dilatation or accompanied by empty-looking 
vacuoles, and elongated cytoplasmic processes (Fig. 
3L, M). The structure of the deeper layers of the dermis 
appeared normal. Large anagen-type follicles were 
prominent in transgenic animals (Fig. 3F,O), but follicles 
in other phases of the hair cycle were visible as well, 
indicating that loss of CD44 expression in follicular ke-
ratinocytes did not block the hair cycle in any given 
phase. There was no obvious relationship between the 
severity of the dermal/epidermal alterations, the sex of 
the mice, and the region of the skin examined (back, ear, 
or tail). However, the observed phenotype was age de- 
pendent. No histologic changes were detected in new- 
born mice. The first basal layer keratinocyte alterations 
appeared at 3 weeks, and the full spectrum of morpho- 
logic changes developed 6 weeks after birth. The de- 
scribed phenotype progressed with maturation and was 
most striking in animals > 18 months of age. 
Loss of keratinocyte CD44 expression is accompanied 
by accumulation of HA in the superficial dermis and 
beneath the corneal epithelium 
In an attempt o identify the loose connective tissue- 
type material observed to accumulate in the superficial 
dermis, we employed mouse CD44-immunoglobulin fu-
sion protein (mCD44Rg), which has proved to be a re- 
agent of choice for localizing HA in tissue sections 
(Aruffo et al. 1990; Fenderson et al. 1993; Bartolazzi et al. 
1994). Immunohistochemical analysis showed marked 
binding of mCD44Rg to the superficial dermis beneath 
the dermoepidermal junction in skin sections from 
transgenic but not from normal mice (Fig. 4A, B). Pre- 
treatment of transgenic mice skin sections with hyal- 
uronidase abrogated mCD44Rg binding to the superficial 
dermis, indicating that the accumulated material is in- 
deed HA (Fig. 4C). 
Because the K5 promoter is active in the corneal epi- 
thelium (Byrne and Fuchs 1993), corneal tissue sections 
from transgenic and control mice were analyzed by his- 
tology and assessed for CD44 expression. Similar to the 
skin, cornea from transgenic mice did not express CD44 
on corneal cells, in contrast o control cornea (data not 
shown), and displayed the same type of structural alter- 
ations, most notably the accumulation of loose connec- 
tive tissue in place of the dense connective tissue nor- 
mally found beneath the corneal epithelium (Fig. 5). The 
loose connective tissue bound CD44Rg (Fig. 5), and bind- 
ing was abrogated by tissue section treatment with hy- 
aluronidase (data not shown). 
Keratinocytes in K5-CD44-antisense transgenic mice 
display a defect in HA uptake 
Immunohistochemical analysis of normal mouse skin 
using mCD44Rg showed hyaluronidase-sensitive punc- 
tiform inter- and intracellular epidermal staining, con- 
sistent with cell-surface binding and internalization of
HA by keratinocytes. In contrast, mCD44Rg failed to 
bind to the epidermis of transgenic mice (Fig. 4A, B). Be- 
cause CD44 has been shown to be involved in the uptake 
and degradation of HA in various cell types (Culty et al. 
1992), this observation is consistent with the possibility 
that the absence of CD44 may result in defective HA 
uptake by keratinocytes. We therefore cultured keratino- 
cytes from dorsal skin of control and transgenic mice in 
the presence of fluorescein-tagged HA (HA-FL) for 1 or 
24 hr. Confocal microscopy revealed cell-surface binding 
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Figure 3. Histological and uhrastructural 
analysis of K5-CD44-antisense transgenic 
mouse skin. Tissue sections of control it- 
termate (c)(A,C,E,G) and transgenic (t) 
(B,D,F,H) mice stained with hematoxylin- 
eosin (A,B,E,F) and van Gieson-elastin 
(C,D). Shown are hair follicles of control 
(E) and transgenic (F) mice; methylene 
blue-stained semithin skin sections from 
control littermate (G) and transgenic (H) 
mice; ultrastructure of control ittermate 
dermoepidermal junction (I), dermal fibro- 
blast (L1, and hair follicles (N) and trans- 
genic mouse counterparts (J,K,M,O). Note 
the elongated appearance of keratinocytes 
(B,H,K), disorganization and disruption of 
collagen bundles (B,D, LK), accumulation 
of loose connective tissue in the superfi- 
cial dermis (D,J,K), vacuoles beneath the 
basement membrane (arrows in H and/), 
dissociation of the basement membrane 
from the underlying collagen bundles (K), 
abnormal fibroblasts with enlarged endo- 
plasmic reticulum and vacuolization (M), 
and large anagen-type follicles (F,O) in 
transgenic animals. Original magnifica- 
tion 40x (A-H); 2800x (I-0). 
of HA-FL at 1 hr and internalization at 24 hr by nor- 
mal but not by CD44-negative transgenic keratinocytes 
(Fig. 6). 
Keratinocytes not only bind and degrade HA but are 
also a site of HA synthesis. To determine whether loss of 
CD44 expression might affect HA synthesis by keratino- 
cytes, we incubated primary keratinocyte cultures from 
transgenic animals and normal ittermates with [3H]glu- 
cosamine and compared the amount of radiolabel incor- 
porated into HA released into the supernatants and re- 
tained in membrane xtracts (Culty et al. 1992; Under- 
hil l et al. 1993). Supernatants from transgenic and 
normal keratinocytes contained comparable radiolabeled 
HA (175 _+ 17 x 10 3 and 162 _+ 26 x 10  3 cpm, respec- 
tively). However, the membrane fraction of the trans- 
genic keratinocytes displayed significantly lower 3H-la- 
beled HA than that of their normal counterparts 
(9.5 _+ 3.9 x 103 and 38.1 _+ 7.6 x 103 cpm, respectively), 
consistent with decreased HA binding. Fibroblasts from 
the superficial dermis of normal and transgenic mice 
showed comparable HA synthesis as assessed by [3H]glu- 
cosamine incorporation (data not shown). 
K5-CD44-antisense transgenic mice display abnormal 
skin elasticity, wound healing, and reaction to TPA 
Handling of transgenic mice showed decreased skin elas- 
ticity in comparison to control littermates. This was 
substantiated by the observation that a simple dorsal in- 
cision conserved its l inearity in control animals but im- 
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Figure 4. mCD44 Rg reactivity with transgenic mouse skin 
sections. Fluorescence micrographs of sections of control litter- 
mate (A) and transgenic (B,C) mice stained with 20 ~g/ml 
mCD44Rg followed by fluorescein-conjugated goat anti-human 
IgG antibodies either without (A,B) or with (C) pretreatment of 
the section with 1 ~g/ml of bovine testicular hyaluronidase. 
The interkeratinocyte staining pattern of mCD44Rg in control 
littermate pidermis (A) is absent in transgenic mouse skin (B). 
The strong reactivity of the transgenic mouse superficial dermis 
with mCD44Rg (B) is abolished following treatment of the sec- 
tion with hyaluronidase (C). The residual staining is attribut- 
able to autofluorescence of the corneal layer. Original magnifi- 
cation, 40x. 
mediately adopted a round shape in transgenic litter- 
mates (Figure 7A, B). Intradermal hyaluronidase injection 
into the transgenic animals 2 hr prior to the incision 
restored elasticity, as assessed by the conservation of in- 
cision linearity, indicating that the reduction in skin 
elasticity in transgenic mice is related to HA accumula- 
tion in the superficial dermis (Fig. 7C). Intradermal in- 
jection of saline buffer, used as a control, failed to restore 
normal skin elasticity (data not shown). 
The effect of keratinocyte CD44 expression loss on 
tissue repair was addressed by comparing the kinetics 
and histology of wound healing in transgenic and normal 
littermates. Single 1-cm 2 full-thickness dorsal wounds 
in control mice underwent complete reepithelialization 
within 12-14 days. In contrast, wound healing was de- 
layed by 4-7 days in transgenic animals (Fig. 7D). In con- 
trol mice, re-epithelialization was preceded by contrac- 
tion of wound margins, formation of a scab, reduction of 
the wound surface, and loss of the scab upon resolution 
of the healing process. In the transgenic mice, contrac- 
tion of the wound margin did not proceed normally and 
a rough yellowish scab persisted for 4-7 days following 
complete healing of the wounds in control mice (Fig. 
7E, F). Examination of wound sections 1, 3, 5, and 7 days 
following full thickness incision revealed that all of the 
stages of wound healing, including leukocyte infiltra- 
tion, granulation tissue formation, fibrosis, and re-epi- 
thelialization, were present in the transgenic mice (data 
not shown). Re-epithelialization appeared to be the 
single most delayed event. Repeated incisions in the 
same wound area of transgenic mice further accentuated 
the delay in tissue repair with respect o normal litter- 
mates (data not shown). 
To address the possible effect of CD44 expression loss 
on keratinocyte proliferation, we performed a bromode- 
oxyuridine (BrdU) incorporation assay. BrdU was in- 
jected into animals in which 0.5-cm 2 wounds had been 
established, and the injured tissue stained with an anti- 
BrdU antibody 2 hr following injection. In control mice 5 
days after injury, a large number of keratinocytes at the 
wound margin incorporated BrdU, whereas the number 
of BrdU-incorporating cells in the epidermis at the 
wound margin of transgenic mice was severalfold lower 
(Figs. 7, G and H, and 8E). Impaired proliferation ap- 
peared to be restricted to keratinocytes, as the BrdU in- 
corporation by cells in the underlying ranulation tissue 
was similar in transgenic and control mice at this stage 
of wound healing. 
We further analyzed keratinocyte proliferation in vivo 
in response to local application of tetradecanoylphorbol 
acetate [(TPA)Akhurst et al. 1988] to ear skin. Stimula- 
tion by TPA caused skin thickening in control mice 
within 48 hr but induced no change in the skin of trans- 
genic littermates. Histologically, the epidermis of the 
control mice displayed a characteristic ncrease in kera- 
tinocyte stratification, whereas epidermal thickening in 
transgenic mice was minimal (Fig. 8A, B). Although 
35%-40% of keratinocytes in the epidermis of control 
mice incorporated BrdU 48 hr after TPA application, 
only a few cells were positive in the transgenic mouse 
epidermis (Fig. 8C). It should be noted that stimulation 
of the skin with TPA induced increased expression of 
CD44 on proliferating keratinocytes in the control mice, 
which was completely absent in the transgenic animals 
(data not shown). Finally, 2 days after TPA application, 
the dermis of control mice showed a marked infiltration 
by polymorphonuclear cells, which was absent in trans- 
genic mice, suggesting an impaired capacity of their al- 
tered skin to mount an acute inflammatory response. 
Figure 5. Corneal abnormalities in transgenic mice. Light 
(A,B) and fluorescence (C,D) microscopy of corneal sections 
from normal (A,C) and transgenic (B,D) mice. Note the accu- 
mulation of loose connective tissue beneath the corneal epithe- 
lium in transgenic mice (B) and its strong reactivity with 
mCD44Rg (D). The dermoepidermal junction in C and D is 
indicated by arrows. Original magnification, 40x. 
1000 GENES & DEVELOPMENT 
 Cold Spring Harbor Laboratory Press on October 19, 2018 - Published by genesdev.cshlp.orgDownloaded from 
Suppression of CD44 in skin 
Figure 6. Uptake of HA-FL by transgenic 
keratinocytes. Epidermal keratinocytes of 
control littermate (A,C) and transgenic 
(B,D) mice were incubated with 100 ]ag/ml 
of HA-FL for 9.4 hr (A,B) or 1 hr (C,D) and 
examined under a confocal microscope. At 
1 hr, normal but not transgenic keratino- 
cytes display cell surface-bound HA-FL. 
After 24 hr, the HA is present inside nor- 
mal but not transgenic keratinocytes. 
Original magnification, 1890x. 
Hair regrowth is delayed in K5-CD44-antisense 
transgenic mice 
We compared hair regrowth in control and transgenic 
mice after pulling out the dorsal hair of the animals fol- 
lowing the second hair cycle. In control mice, hair re- 
grew normally within 10 days, whereas in transgenic 
mice hair regrowth was delayed for at least 5 days. Hair 
follicle keratinocyte proliferation was assessed by BrdU 
labeling 2 days after plucking. In control mice 39% (+4) 
of follicular keratinocytes in the depilated area incorpo- 
rated BrdU, whereas in transgenic mice only 6% (+2) of 
the corresponding follicular keratinocytes were BrdU 
positive (data not shown). Histologic examination ofhair 
follicles at a series of time points following birth, which, 
in normal mice, correspond to different phases of the 
hair cycle (Andreasen 1953; Cotsarelis et al. 1990), re- 
vealed that the transgenic mice display all of the normal 
follicular phenotypes (data not shown), indicating that 
loss of CD44 expression does not result in any obvious 
disruption of the hair cycle. 
Carcinogen application fails to induce epidermal 
hyperplasia in transgenic mice 
To further address the effect of CD44 expression loss on 
the epidermal response to inducers of proliferation, the 
carcinogenic hydrocarbon 7,12-dimethylbenz [a]anthra- 
cene [(DMBA) Andreasen and Borum 1958] in benzene 
was applied to the dorsal skin of control and transgenic 
mice that were in the resting phase of their hair cycle. 
Twenty days following DMBA treatment, all of the con- 
trol animals displayed severe ulcerative lesions with ex- 
sudation and hair loss at the site of DMBA application in 
contrast o transgenic mice, which revealed only minor 
lesions. The ulcerations persisted for at least 40 days in 
normal mice while the minor lesions visible in trans- 
genic counterparts disappeared within 15 days. Histo- 
logic examination of the skin on day 60 following DMBA 
application revealed chronic ulceration with moderate to 
severe lymphocyte and granulocyte infiltration in nor- 
mal mice (data not shown). The epidermis at the margin 
of the ulcer displayed marked hyperplasia with enlarged 
hair follicles (Fig. 9A). In contrast, the epidermis of trans- 
genic mice failed to display ulcerative or hyperplastic 
changes (Fig. 9B). 
Defective in vitro proliferation of K5-CD44-antisense 
transgenic mouse keratinocytes in response to injury, 
mitogen, and growth factors 
To determine whether the observed lack of proliferation 
in response to injury, TPA, and possibly carcinogen is 
associated with HA accumulation i the superficial der- 
mis or reflects a primary defect, cultured transgenic and 
normal ittermate keratinocytes were tested for response 
to 1 ng/ml of TPA and 0.5-5 mg/ml of HA. Exposure to 
TPA resulted in increased proliferation of normal kera- 
tinocytes but failed to stimulate transgenic counterparts 
(Fig. 10A). Incubation with low concentrations of HA 
resulted in a slight but significant increase in ormal 
keratinocyte proliferation but again failed to stimulate 
transgenic ells (Fig. 10A). Because keratinocytes nor- 
mally express everal CD44 isoforms, including exon v3- 
containing variants, which are substituted in heparan 
sulfate side chains and bind basic fibroblast growth fac- 
tor (bFGF) and heparin-binding epidermal growth factor 
[(HB-EGF) Bennett et al. 1995], we compared the ability 
of transgenic and normal ittermate keratinocytes topro- 
liferate in response to bFGF and HB-EGF. Amphiregulin 
(AR), which fails to bind CD44v3 (Bennett et al. 1995), 
was used as a negative control. Normal keratinocytes 
displayed increased proliferation in response to 0.5 ng/ 
ml of bFGF and 5 ng/ml of HB-EGF, whereas transgenic 
keratinocytes failed to show proliferative response. Nei- 
ther cell type proliferated in response to AR at the con- 
centration used (Fig. 10B). 
Discuss ion  
Previous work by others has demonstrated the feasibility 
of suppressing gene expression using an antisense cDNA 
expression strategy (Katsuki et al. 1988; Pepin et al. 
1992). In the present work we have achieved tissue-se~ 
lective suppression of CD44 expression by introducing 
the mouse CD44 cDNA in antisense orientation under 
the control of the keratinocyte-specific K5 promoter 
(Ramirez et al. 1994). Because the K5 promoter has also 
been used to overexpress an antisense bcl2 transgene in 
the keratinocytes of transgenic mice which, despite ex- 
pression of the transgene, failed to produce any detect- 
able phenotypic alteration (I. Rodriguez and P. Vassalli, 
unpubl.), the effects of K5-CD44AS vector expression 
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Figure 7. Analysis of wound healing in transgenic mice. Single 
full-thickness incisions (A-C) or 1 (D-F) or 0.5 (G,H) cm 2- 
square-shaped wounds were made on the back of control itter- 
mate (A,E,G) and transgenic (B,C,F,H) mice as described in Ma- 
terials and Methods. The linear shape of the incision in the 
control ittermate (A) is not conserved in the transgenic mouse, 
and incision immediately becomes round-shaped (B), consistent 
with abnormal skin elasticity. Intradermal injection of bovine 
testicular hyaluronidase 2 hr prior to the incisions restores the 
incision shape in the transgenic mouse (C). Healing of l-cm 2 
square-shaped wounds is delayed in transgenic mice (D). The 
data represent mean values from five transgenic mice (©) and 
five control ittermates (0). Data were grouped by measuring 
the wound surface areas every 2 days after wounding by planim- 
etry until complete healing was reached in the control mice. 
The surface area of the wound expressed as a percentage of the 
wound surface area at day 0 was calculated for each animal. 
Square shaped wounds (1 cm 2) were reepithelialized almost 
completely after 12 days in the control mice (E), whereas in the 
transgenic mice an abnormal scab was observed after the same 
period of time (F), which persisted for another 4-7 days. Shown 
is BrdU labeling of keratinocytes at the wound margin of control 
(G) and trangenic (H) mice. A single full-thickness 0.5-cm 2
wound was made on the back of control and transgenic mice. 
On day 5 following injury, mice were injected with BrdU (250 
mg/kg) and 2 hr later wound tissue was isolated and processed 
for sectioning. Mid-wound sections were stained with a fluores- 
cein-conjugated anti-BrdU antibody. Original magnification, 
20x. 
reported here are unl ike ly  to represent the nonspecif ic 
consequence of excessive K5 promoter usage but, rather, 
reflect the loss of cell-surface CD44. Abrogation of kera- 
t inocyte CD44 expression in mice was observed to have 
at least two major consequences: (1)the loss of HA in the 
interkeratinocyte spaces accompanied by abnormal ac- 
cumulation of HA in the superficial dermis, and (2) the 
inhibition of keratinocyte proliferation in response to a 
variety of extracellular stimuli. These changes were as- 
sociated with defects in skin elasticity, tissue repair, hair 
regrowth, and local inflammatory response and with 
lack of induction of epidermal hyperplasia following ex- 
posure to carcinogen, all of which may be interpreted as 
resulting from the two basic consequences of the loss of 
CD44 expression. 
Keratinocytes and fibroblasts provide the principal 
source of HA in the epidermis and dermis, respectively. 
There is evidence that fibroblasts are also capable of in- 
ternalizing HA, which leads to its subsequent degrada- 
tion, and that this phenomenon is CD44-mediated (Ber- 
tolami et al. 1992). In this study we have shown that 
keratinocytes that are unable to express CD44 are also 
unable to bind and internalize HA in vitro, whereas their 
capacity to synthesize HA is unimpaired. It thus appears 
that CD44 expressed in keratinocytes and fibroblasts 
may play a major role in HA turnover in the skin, as 
shown by the absence of HA in the interkeratinocyte 
spaces of the transgenic mice, contrasting with its pres- 
ence at this location in normal animals (Tammi et al. 
1988, 1991; Wang et al. 1992; G. Kaya et al., this work). 
Because normal and transgenic fibroblasts howed com- 
parable HA synthesis in vitro, HA accumulation is not 
likely to result from overproduction by local fibroblasts 
A - "  ....... ° . . . .  ........ B 
C 4O 







none wound TPA 
/ 
Figure 8. Analysis of keratinocyte proliferation in vivo after 
TPA application. TPA (10 -4 M) was applied to each side of the 
ear of control and transgenic mice. Two days after TPA appli- 
cation, control mice displayed thickened epidermis with 
marked edema nd a cellular infiltrate (A), whereas transgenic 
mouse pidermis revealed virtually no thickening (B). (C) Quan- 
tification of BrdU-positive cells in sections 2 days after TPA 
application to transgenic mice (solid bars) and controls (open 
bars); positive cells were scored in five microscopic fields in 
each section. Original magnification, 40x. 
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Figure 9. Effect of CD44 expression the 
response to local carcinogen application. 
Skin section of control (A) and transgenic (B) 
mice 60 days following application of 
DMBA. Note the pronounced epidermal hy- 
perplasia of control mice in contrast to the 
normal-appearing epidermis of transgenic 
animals. Original magnification, 40x. 
but, rather, from a failure of keratinocytes to maintain it 
within the epidermis and to degrade the HA that they 
produce. The abnormal ultrastructural features of super- 
ficial dermal fibroblasts and their increased expression of 
CD44 may reflect activation by excess local HA and/or 
enhanced CD44-mediated HA internalization. 
What is the role of HA maintained in the interkera- 
tinocyte spaces through CD44 binding? Interactions be- 
tween CD44 and HA may contribute to the regulation of 
the intercellular space, whose alteration in the trans- 
genic mice may explain the change in morphology of 
basal keratinocytes. This view is supported by a recent 
study showing that CD44 participates in cell-cell inter- 
actions among keratinocytes (Hudson et al. 1995). Fur- 
thermore, the fact that HA attracts water molecules and 
helps create a hydrated, low-resistance matrix also sug- 
gests that maintenance of extracellular space in the epi- 
dermis may be one of its major functions, perhaps of 
particular importance in a stratified epithelium where 
the distance to the most superficial layers of the blood 
capillaries may be significant. The age-dependent aug- 
mentation of HA accumulation and associated histologic 
changes could be explained by a progressive increase in 
keratinocyte HA production or reduction in the effec- 
tiveness of CD44-independent mechanisms ofHA elimi- 
nation. Further work will be required to resolve this 
point. 
The second major effect of CD44 expression loss by 
keratinocytes is a defect in their ability to proliferate in 
response to various stimuli in vivo and in vitro. The 
baseline proliferation appeared unaltered, as skin and 
corneal development were normal and resting state 
transgenic and normal keratinocytes displayed compa- 
rable proliferation rates in vitro. The reduced ability of 
cultured transgenic keratinocytes to proliferate in re- 
sponse to bFGF and HB-EGF is not unexpected, as both 
factors bind heparan sulfate side chains of CD44v3-con- 
taining isoforms (Bennett et al. 1995), which appear to 
constitute a major fraction of heparan sulfate proteogly- 
cans expressed on the surface of normal keratinocytes 
(Hudson et al. 1995). Taken at face value, the inability of 
transgenic keratinocytes to proliferate in response to 
bFGF and HB-EGF would suggest hat heparan sulfate- 
associated CD44 isoforms play a significant role in pre- 
senting these growth factors to their respective receptors 
in keratinocytes and may help explain the low keratino- 
cyte proliferation rate in vivo following injury. Similarly, 
the impaired transgenic mouse keratinocyte prolifera- 
tive response to exogenous HA may be explained by the 
inability of these cells to bind and internalize HA. Inter- 
action between CD44 and ECM HA significantly en- 
hances growth of various tumor types in vivo (Sy et al. 
1991; Bartolazzi et al. 1994), and there is evidence that 
engagement of CD44 by HA may have a costimulatory 
effect on cytokine or growth factor-mediated c ll activa- 
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Figure 10. Keratinocyte proliferation in response to exogenous st imuli  in vitro. Keratinocytes from normal and transgenic mice were 
grown on postmitot ic  fibroblast feeder layers at a ratio of 1:6 in 96-well plates. On day 12 of culture, TPA or HA (A) and heparin-binding 
bFGF, HB-EGF, or AR (B) were added to the wells at the indicated concentrations. Forty-eight hours later, 1 pCi of [aH]thymidine was 
added to each well and isotope incorporation evaluated 24 hr later. All experiments were done in triplicate. 
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et al. 19941. However, because xpression of all keratino- 
cyte CD44 isoforms is suppressed in our model and be- 
cause both heparin-binding growth factors and hyaluro- 
nan are likely to stimulate keratinocyte proliferation in 
vivo, it is difficult at present o distinguish effects that 
result primarily from transgenic keratinocyte inability 
to bind bFGF and HB-EGF from those predominantly 
related to their inability to bind and internalize HA. In- 
terestingly, loss of CD44 expression is also associated 
with keratinocyte inability to mount a proliferative re- 
sponse to phorbol ester both in vitro and in vivo, in stark 
contrast with the rapid epithelial thickening and kera- 
tinocyte CD44 overexpression following phorbol ester 
stimulation of the skin of normal animals. These obser- 
vations suggest either that the CD44 polypeptide and/or 
its associated glycosaminoglycan side chains are impli- 
cated in the regulation of phorbol ester-triggered kera- 
tinocyte stimulation, a hitherto unrecognized role, or 
that CD44 may participate in more general signaling 
events required for the induction of keratinocyte prolif- 
eration by a broad range of extracellular stimuli. 
All of the other consequences of the loss of CD44 ex- 
pression in the epidermis that we observed in the trans- 
genic mice, namely, decreased skin elasticity, delayed 
wound healing, impaired hair regrowth, and absence of
epidermal hyperplasia in response to carcinogen, may be 
attributed to inappropriate HA accumulation, defective 
keratinocyte proliferation, or a combination of both. Ac- 
cumulation of HA in the superficial dermis appeared to 
be the single most important factor in the observed loss 
of skin elasticity, as normal elasticity was temporarily 
restored following HA removal by local hyaluronidase 
injection. Delayed wound healing is most likely attrib- 
utable to a combination of reduced skin elasticity (which 
increases the size of the wound), defective keratinocyte 
proliferation in response to external stimuli, and possi- 
bly impaired keratinocyte migration. CD44 is highly ex- 
pressed in migrating keratinocytes atall stages of healing 
of human mucosal wounds (Oksala et al. 1995), and 
CD44 expression has been shown to promote cell migra- 
tion directly on HA-coated substrates (Thomas et al. 
1992). Ineffective interaction with HA because of CD44 
loss can therefore be expected to at least partially inhibit 
HA-dependent keratinocyte migration through ECM. 
Delay in hair regrowth may be best explained by the 
observed efective proliferation in hair bulbs after hair 
pulling, as hair regrowth depends in part on the ability of 
follicular keratinocytes to proliferate. Importantly, ab- 
sence of CD44 expression did not abrogate hair cycling, 
as all of the phases that constitute the normal hair cycle 
were visible in the transgenic animals. However, we can- 
not exclude the possibility that hair cycle duration may 
have been altered. 
Finally, impaired solute uptake and/or diffusion be- 
cause of subepidermal HA accumulation and associated 
epidermal structural changes, and not only the impaired 
ability of keratinocytes to proliferate, may also be an 
important factor in the lack of epidermal hyperplasia in 
response to carcinogen observed in the transgenic mice. 
It has been suggested that topical carcinogen induction 
of permanent hyperplasia nd skin papillomas in mice 
requires mutations in bulge cells that are reached by the 
carcinogen only in the resting phase of hair growth (An- 
dreasen and Engelbreth-Holm 1953; Borum 1954; Cot- 
sarelis 1990). Impaired diffusion in transgenic mice 
could result in the reduced ability of carcinogen to reach 
the critical target cells. 
Taken together, our observations provide strong sup- 
port for the concept that keratinocyte CD44 regulates 
local HA metabolism and thereby participates in the 
control of intercellular communication and epidermal 
permeability. However, they also indicate that CD44 is 
implicated in the regulation of keratinocyte proliferation 
in response to a variety of extracellular stimuli. The 
transgenic animals presented here will provide a means 
to address the molecular mechanisms of CD44-mediated 
keratinocyte proliferation control. 
Mater ia ls  and methods  
Isolation of murine CD44 eDNA 
Full-length murine CD44H (mCD44H) cDNA was amplified by 
PCR from MRL/lpr mouse lymph node-derived eDNA template 
using synthetic oligonucleotide primers containing HindIII and 
XhoI restriction sites for the 5' and 3' ends of the coding region, 
respectively: forward primer, 5'-CGCGGGAAGCTTATGGA- 
CAAGTTTTGGTGGCACAC-AGCTTGG-3'; reverse primer, 
5'-CGCGGGCTCGAGCTACAC-CCCAATCTTCATGTCCA- 
CA-CTCTG-3'. Thirty-five cycles of PCR amplification were 
performed, consisting of 1 min at 94°C, 2 min at 55°C, and 3 
min at 72°C in a 100-~l reaction mix containing 10 mM Tris- 
HC1 (pH 8.3), 50 mM KC1, 1.5 mM MgC12, 200 ~M each dNTP, 
the appropriate primers at 750 nM, and 1 unit of Taq polymerase 
(Perkin Elmer Cetus, Emeryville, CA). Amplified mCD44H 
cDNA was subsequently inserted into the pBluescript (pBS) SK+ 
cloning vector using the restriction enzyme cleavage sites to 
yield the mCD44H-pBS vector. The cDNA was assessed for 
PCR-induced mutations by direct dideoxy sequencing. 
Construction of the K5p-mCD44AS transgene and generation 
of transgenic mice 
The 5.2-kb fragment of the bovine K5 gene 5' regulatory region 
(K5p) (Ramirez et al. 1994)was ubcloned into pBS KS+ vector to 
yield the K5p-pBS plasmid, mCD44H eDNA was excised with 
HindIII-XhoI from mCD44H-pBS, blunted, and introduced in 
an antisense orientation into the blunted EcoRI site between 
the rabbit ~-globin intron and polyadenylation sequences of 
~glob-pBS to yield ~3glob-mCD44AS. The ~-globin intron, an- 
tisense mCD44H, and ~-globin polyadenylation sequence were 
removed from ~glob-mCD44AS with SpeI-XhoI, blunted, and 
inserted into the SmaI site, downstream of K5p, in K5p-pBS to 
yield K5p-mCD44AS. Transgenic mice were generated as de- 
scribed previously (Hogan et al. 1986). The transgene construct 
was excised from the plasmid vector as a SalI-NotI fragment, 
purified by agarose gel electrophoresis and NACS columns (BRL 
Life Technologies, Inc., Gaithersburg, MD) and resuspended in
microinjection buffer (1 mM Tris-HcI at pH 7.4 and 0.1 mM 
EDTA at pH 8.0) to a final concentration of 5 ng/~l. C57BL/ 
6 x DBA/2 F1 females were superovulated bysequential intra- 
peritoneal injections of 5 units of pregnant mare serum (Sigma 
Chemical Co., St. Louis, MO) and 5 IU of human chorionic 
gonadotropin (Sigma) andmated with fertile F 1 males. Single- 
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cell embryos were harvested the following day using M16 me- 
dium (Whittingham). Cumulus cells were removed by brief in- 
cubation in 1 mg/ml of bovine testicular hyaluronidase (Sigma). 
Pronuclei were microinjected with -1-2 pl of the transgene con- 
struct DNA, and the injected embryos were reimplanted into 
pseudopregnant NMRI outbred female mice on the same day. 
DNA isolation and analysis 
Tail biopsy tissue was digested at 50°C for 4-6 hr in 0.5 ml of 
extraction buffer (10 mM Tris-HC1 at pH 7.5, 1 mM EDTA, 0.8x 
SSC, 1% SDS) containing 20 ~g of proteinase K and 10 ~g of 
RNase. Restriction endonuclease digestion, agarose gel electro- 
phoresis, and Southern blotting of purified DNA were per- 
formed according to standard procedures. 
Analysis of antisense RNA expression 
Total RNA preparation from the back skin of mice and reverse 
transcription were done as described above. Using oligonucleo- 
tides specific for the antisense CD44 cDNA strand and the 
poly(A) sequence, PCR was performed as described above xcept 
that the reaction mix was 20 ~1 and 27 cycles were conducted. 
The following primers were used: ASForward, 5'- 
TATATACTCCTGTCTGGTTGGCTGCAC-3', and pTX, 5'- 
CCCCTCGAGTTTTTTTTTTTTTTT-3'. Southern blotting on 
10 ~1 of each PCR product using 1.1 kb of entire mCD44H 
cDNA was performed as described above. 
Production and purification of mCD44Rg fusion protein 
The cDNA sequence encoding the extracellular portion of 
mCD44 was amplified by PCR as described above using 
mCD44H plasmid as a template and synthetic primers contain- 
ing HindIII and BglII restriction sites for the 5' and 3' extremi- 
ties, respectively. After sequencing, the amplified cDNA seg- 
ment was digested with the appropriate r striction enzymes and 
ligated to CDM8-immunoglobulin vector (Aruffo et al. 1990). 
The mCD44-immunoglobulin vector was introduced into COS 
cells by the DEAE-dextran method, and 5-7 days post-transfec- 
tion, supernatants were harvested and soluble CD44Rg purified 
on protein A-trisacryl beads (Pierce Chemical Co., Rockford, tL 1 
as described (Aruffo et al. 1990; Bartolazzi et al. 1994). 
Anti-CD44 and mCD44Rg staining of skin sections 
CD44 and HA detection was performed on cryostat sections of 
skin samples that were frozen in liquid nitrogen. Cryostat sec- 
tions (5 ~m) were mounted onto slides, air-dried, preincubated 
with 10 ~g/ml of goat IgG (Cappel, Malvern, PA) for 20 min at 
room temperature, and incubated with rat anti-mouse CD44 
antibodies (2.5 ~g/ml) or mCD44Rg purified protein (-20 ~g/ 
ml) for 1 hr at room temperature. Hyaluronidase treatment of 
tissues was performed by incubating frozen tissue sections with 
1 ~g/ml of bovine testicular hyaluronidase (Sigma) in PBS for 1 
hr at 37°C. After staining with the primary reagent, sections 
were washed three times with PBS, 5% FCS, and 0.02% NAN3; 
incubated with FITC-labeled affinity-purified goat anti-rat im- 
munoglobulin or goat anti-human IgG (Cappel) antibodies for 
anti-CD44 and mCD44Rg, respectively, for 30 min at room 
temperature; washed; and examined under a Zeiss Axiophot 
microscope using appropriate filters. 
Histology and electron microscopy 
Skin samples were fixed in formaldehyde and embedded in par- 
affin. Sections were cut at 4-8 ~m, mounted onto slides, and 
stained with hematoxylin-eosin and van Gieson-elastin accord- 
ing to standard procedures. One-millimeter cubes from skin 
samples were fixed for 4 hr at room temerature in 2% glutaral- 
dehyde (Merck, Darmstadt, Germany) in 0.1 M Na cacodylate 
(Merck) buffer and stored in buffer overnight at 4°C. The 
samples were postfixed in 2% OsO4 (Merck), dehydrated in 
graded ethanols, and embedded in Epon 812 (Fluka Chemie AG, 
Bushs, Switzerland). Semithin sections were stained with meth- 
ylene blue. Representative areas were s lected for thin sections, 
collected on copper grids, double-stained with uranyl acetate 
and lead citrate (Merck), and examined with a Philips 400 elec- 
tron microscope (Philips SA, Zurich, Switzerland). 
Keratinocyte isolation and culture 
Isolation of epidermal keratinocytes and establishment of hu- 
man dermal fibroblast (HDF) feeder layers were carried out as 
described previously (Limat and Hunziker 1996; Limat et al. 
1989). Briefly, 0.5 cm 2 full-thickness back skin of mice was cut 
into four sections and treated with 1 U/ml of dispase (Boe- 
hringer Mannheim) in Dulbecco's modified Eagle medium 
(DMEM) supplemented with 10% FCS overnight at 4°C. The 
epidermis was then detached from the dermis, rinsed with PBS, 
and incubated with 0.1% trypsin (1:250) and 0.02% EDTA in 
PBS without Ca 2÷ and Mg 2+ (pH 7.2) for 10 min at 37°C. A 
suspension essentially consisting of single cells was obtained by 
pipetting the epidermis vigorously in DMEM supplemented 
with 10% DMEM. After centrifugation for 10 min at 200g, epi- 
dermal keratinocytes were resuspended in culture medium and 
seeded at a density of 0.5 x 103 to 1 x 103 cells/cm 2 on a HDF 
feeder layer. Primary cultures were performed in FED medium 
(a kind gift of Dr. A. Limat, University of Berne, Berne, Swit- 
zerland) composed of three parts DMEM and one part Ham's 
F12 supplemented with 10% FCS, insulin, hydrocortisone, ad- 
enine, triiodothyronine, choleratoxin, epidermal growth factor 
(EGF), penicillin, and streptomycin (Limat and Hunziker 1996). 
Determination of keratinocyte HA binding and uptake and 
HA synthesis in vitro 
Keratinocytes were cultured in six-well culture plates (Falcon, 
Becton Dickinson and Co., Franklin Lakes, NJ) as described 
above. HA-FL (100 lug/ml) or mCD44Rg (100 lag/mll was added 
to the wells, and the cultures were maintained at37°C for 1 or 
24 hr. The cells were washed with PBS, fixed for 3 min in 
methanol at -20°C, mounted in polyvinylalcohol, and exam- 
ined with a Zeiss LSM 410 confocal microscope (Carl Zeiss, 
Germany). HA synthesis was determined according to methods 
described previously (Culty et al. 1992). Keratinocytes from 
transgenic and normal mice were incubated with fresh medium 
containing 20 ~aCi/ml of [3H]glucosamine at 37°C for 24 hr. The 
culture media were collected and the cells were incubated with 
0.05% trypsin, 0.02% EDTA (GIBCO), at 37°C for 30 min to 
release cell-surface HA. Trypsinized material was separated 
from the cells by centrifugation. Both medium and trypsinate 
were digested with 0.5 % protease (type XIV, Sigma) overnight at 
37°C, boiled for 10 min to inactivate the protease, and centri- 
fuged to separate denatured proteins from the supernatant. Car- 
rier HA and chondroitin sulfate (20 ~g/0.6ml) were added to the 
HA-containing supernatant, and the HA was precipitated with 
10% cetylpyridinium chloride (CPC) at 37°C for 1 hr. HA pre- 
cipitates were centrifuged at10,000g for 10 min, and the pellets 
GENES & DEVELOPMENT 1005 
 Cold Spring Harbor Laboratory Press on October 19, 2018 - Published by genesdev.cshlp.orgDownloaded from 
Kaya et al. 
were washed twice in 0.2% CPC and dissolved in 0.5 ml of 
methanol. Scintillation liquid was added to the methanol re- 
solved solution and the radiolabel incorporation determined in
a ~ counter. 
Wound healing experiments 
Experimental wounds were created in the dorsal skin of control 
and transgenic mice. Mice were anesthetized with a single in- 
traperitoneal injection of Avertin [8 mg in 0.3 ml of NaC1 (9 
grams/liter)]. A square-shaped full-thickness wound of 0.5 or 1 
cm 2 was made on the back by excising skin and panniculus 
carnosus. Animals with 0.5-cm 2wounds were sacrificed or sub- 
jected to biopsy at day 5 after injury or after complete healing in 
control mice. The surface areas of 1-cm 2 wounds were measured 
by planimetry every 2 days after wounding until complete heal- 
ing was obtained in the control mice. Incisions (10 mm long, 1 
mm wide, and 1-2 mm deep) were made on the back of mice, 
and biopsies were performed at day 1, 3, 5, and 7 after injury. 
Bovine testicular hyaluronidase (100,000 U/kg, Sigma) or NaC1 
(9 grams/liter) control was injected intradermally 2 hr before 
the incisions. 
In vivo and in vitro keratinocyte proliferation assays 
TPA [200 ~1 of 10 -4 M solution in acetone as described by 
Akhurst et al. (1988)] was applied topically to each side of left 
ears of control and transgenic mice. Right ears were treated only 
with acetone. Two days after TPA application, a BrdU labeling 
experiment was performed. Interfollicular keratinocytes from 
control and transgenic mice were grown on postmitotic fibro- 
blast feeder layers in 96-well plates at a ratio of 1:6. On day 12 
of culture, TPA (1 ng/ml), HA (0.5 and 5 mg/ml), human bFGF 
(0.5 ng/ml, R&D Systems Inc., Minneapolis, MN), human hep- 
arin-binding EGF (HB-EGF, 5 ng/ml, R&D Systems), or human 
amphiregulin (AR, 1 ng/ml, R&D Systems) was added to the 
cultures. Forty-eight hours later 1 ~aCi of [3H]thymidine (Amer- 
sham) was added to each well. Isotope incorporation was evalu- 
ated 24 hr later in a Beckman LS 1801 f~ counter (Beckman, 
Irvine, CA). All experiments were done in triplicate, and the 
results were expressed as the mean of incorporated counts per 
minute for each condition tested. 
Analysis of hair regrowth and hair cycle 
Five 12-day-old and ten 24-day-old mice were subjected to skin 
biopsy and histologic examination. Hairs of the control and 
transgenic mice, which were in the resting phase after the sec- 
ond hair cycle (between 30 and 65 days old) were plucked to 
form a 0.5-cm 2 hairless area on the back skin. After 10 days 
when the first hair regrowth occurred, the same procedure was 
repeated and the second regrowth was analyzed. 
BrdU labeling 
On day 2 after TPA application and after hair plucking, on day 
3 after incision, or on day 5 after 0.5-cm 2wound injuries, mice 
were injected intraperitoneally with BrdU (Sigma; 250 mg/kg of 
body weight) and subjected to ear or back skin biopsies 2hr after 
injection. Detection of BrdU on 4-~m paraffin sections with 
anti-BrdU antibodies was performed by using the BrdU Labeling 
and Detection Kit I of Boehringer Mannheim Biochemical 
GMBH (Mannheim, Germany). BrdU-positive and -negative 
cells were scored per microscopic field, and the percentage of
cells incorporating BrdU was calculated. Five microscopic fields 
were examined per mouse, and a total of five mice were used in 
each experiment. 
Carcinogen application 
Fifty microliters of a 0.5% solution of 7,12-dimethylbenz[a]- 
anthracene (DMBA, Aldrich Chemical Co., Milwaukee, WI) in 
benzene (Merck) was applied to shaved dorsal skin of control 
and transgenic mice. Mice were examined two to three times 
weekly, and the carcinogen-treated skin regions were subjected 
to biopsy 60 days following treatment. 
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